share_log

康方生物:股東週年大會通告

AKESO: NOTICE OF ANNUAL GENERAL MEETING

HKEX ·  Jun 6 16:42

Summary by Futu AI

康方生物科技(開曼)有限公司(「康方生物」)將於2024年6月30日舉行股東週年大會,地點為中國廣東省中山市。會議將審議多項普通決議案,包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表及董事會與核數師報告。此外,將進行董事重選,包括夏瑜博士、李百勇博士及王忠民博士的執行董事職位。會上還將續聘安永會計師事務所為核數師並授權董事會釐定酬金。大會將考慮授權董事在特定期間內配發新股份或購回公司股份,並將審議修訂2021年受限制股份單位計劃及購股權計劃。股東將有權委任代表出席大會並投票,而股份過戶登記將於2024年6月25日至30日暫停。董事會成員包括夏瑜博士(主席兼執行董事)、李百勇博士、王忠民博士、夏羽先生、周伊博士、謝榕剛先生、曾駿文博士、徐岩博士及TAN Bo先生。
康方生物科技(開曼)有限公司(「康方生物」)將於2024年6月30日舉行股東週年大會,地點為中國廣東省中山市。會議將審議多項普通決議案,包括審核及採納截至2023年12月31日止年度的經審核綜合財務報表及董事會與核數師報告。此外,將進行董事重選,包括夏瑜博士、李百勇博士及王忠民博士的執行董事職位。會上還將續聘安永會計師事務所為核數師並授權董事會釐定酬金。大會將考慮授權董事在特定期間內配發新股份或購回公司股份,並將審議修訂2021年受限制股份單位計劃及購股權計劃。股東將有權委任代表出席大會並投票,而股份過戶登記將於2024年6月25日至30日暫停。董事會成員包括夏瑜博士(主席兼執行董事)、李百勇博士、王忠民博士、夏羽先生、周伊博士、謝榕剛先生、曾駿文博士、徐岩博士及TAN Bo先生。
Akeso (Cayman) Limited will hold its shareholder's annual meeting on June 30, 2024 in Zhongshan, Guangdong Province, China. The meeting will consider various ordinary resolutions, including the approval and adoption of audited financial statements and auditor's report for the year ended December 31, 2023, as well as the re-election of directors, including Dr. Xia Yu, Dr. Li Baiyong, and Dr. Wang Zhongmin as executive directors. The meeting will also reappoint Ernst & Young as the auditor and authorize the Board of Directors to fix their remuneration. The meeting will consider authorizing the directors to allot new shares or buy back company shares during specific periods and will review the amendment of the 2021 restricted share units plan and share purchase plan. Shareholders have...Show More
Akeso (Cayman) Limited will hold its shareholder's annual meeting on June 30, 2024 in Zhongshan, Guangdong Province, China. The meeting will consider various ordinary resolutions, including the approval and adoption of audited financial statements and auditor's report for the year ended December 31, 2023, as well as the re-election of directors, including Dr. Xia Yu, Dr. Li Baiyong, and Dr. Wang Zhongmin as executive directors. The meeting will also reappoint Ernst & Young as the auditor and authorize the Board of Directors to fix their remuneration. The meeting will consider authorizing the directors to allot new shares or buy back company shares during specific periods and will review the amendment of the 2021 restricted share units plan and share purchase plan. Shareholders have the right to appoint representatives to attend and vote at the meeting, while share transfers will be suspended from June 25 to 30 in 2024. Members of the board of directors include Dr. Xia Yu (Chairman and Executive Director), Dr. Li Baiyong, Dr. Wang Zhongmin, Mr. Xia Yu, Dr. Zhou Yi, Mr. Xie Ronggang, Dr. Zeng Junwen, Dr. Xu Yan, and Mr. Tan Bo.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.